Free Trial

SelectQuote (NYSE:SLQT) Shares Down 9% - Time to Sell?

SelectQuote logo with Finance background
Remove Ads

Shares of SelectQuote, Inc. (NYSE:SLQT - Get Free Report) fell 9% during trading on Tuesday . The company traded as low as $3.88 and last traded at $3.89. 616,385 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 1,241,200 shares. The stock had previously closed at $4.27.

Analyst Upgrades and Downgrades

A number of research firms recently commented on SLQT. Noble Financial raised SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $4.00 price target on shares of SelectQuote in a research note on Friday, November 22nd.

Get Our Latest Stock Report on SelectQuote

SelectQuote Stock Performance

The company has a quick ratio of 6.36, a current ratio of 6.36 and a debt-to-equity ratio of 2.10. The stock has a market cap of $610.25 million, a price-to-earnings ratio of -39.39 and a beta of 1.13. The company has a 50 day simple moving average of $4.45 and a 200 day simple moving average of $3.30.

SelectQuote (NYSE:SLQT - Get Free Report) last issued its earnings results on Monday, February 10th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.09 by $0.21. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. As a group, equities research analysts forecast that SelectQuote, Inc. will post -0.07 EPS for the current year.

Remove Ads

Insiders Place Their Bets

In other news, insider Sarah Taylor Anderson sold 50,000 shares of the company's stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $5.44, for a total value of $272,000.00. Following the completion of the transaction, the insider now owns 1,166 shares of the company's stock, valued at $6,343.04. This represents a 97.72 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 11.40% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Barclays PLC increased its stake in shares of SelectQuote by 166.8% in the third quarter. Barclays PLC now owns 198,357 shares of the company's stock valued at $430,000 after buying an additional 124,005 shares during the period. JPMorgan Chase & Co. increased its stake in shares of SelectQuote by 36.9% in the third quarter. JPMorgan Chase & Co. now owns 429,656 shares of the company's stock valued at $932,000 after buying an additional 115,865 shares during the period. KCM Investment Advisors LLC acquired a new position in shares of SelectQuote in the third quarter valued at approximately $608,000. SG Americas Securities LLC increased its stake in shares of SelectQuote by 10.5% in the fourth quarter. SG Americas Securities LLC now owns 91,508 shares of the company's stock valued at $340,000 after buying an additional 8,660 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of SelectQuote by 1.4% in the third quarter. Geode Capital Management LLC now owns 3,081,391 shares of the company's stock valued at $6,688,000 after buying an additional 43,197 shares during the period. Institutional investors and hedge funds own 34.59% of the company's stock.

About SelectQuote

(Get Free Report)

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.

Featured Articles

Should You Invest $1,000 in SelectQuote Right Now?

Before you consider SelectQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.

While SelectQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads